Raquel E. Izumi - 14 Dec 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
President and Chief Operations Officer, Director
Signature
By: /s/ Raquel E. Izumi
Issuer symbol
VINC
Transactions as of
14 Dec 2022
Net transactions value
+$25,427
Form type
4
Filing time
14 Dec 2022, 20:22:49 UTC
Previous filing
17 Nov 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $25,427 +28,738 +72% $0.8848 68,738 14 Dec 2022 Izumi-Covey 2000 Revocable Trust U/A 01/09/01 F1
holding VINC Common Stock 1,000 14 Dec 2022 By spouse's Rollover IRA
holding VINC Common Stock 1,618,199 14 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $0.85 to $0.89 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.

Remarks:

President and Chief Operations Officer